Harvard Bioscience to Participate in Upcoming Investor Conferences
Harvard Bioscience to Participate in Upcoming Investor Conferences
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Harvard Bioscience to Participate in Upcoming Investor Conferences
Earnings call transcript: Harvard Bioscience Q3 2025 misses EPS forecast
Harvard Bioscience receives extension to regain Nasdaq bid price compliance